AKT-IN-28
Product Specifications
Target
Apoptosis|||PARP|||Caspase|||Akt|||Wnt/beta-catenin
Related Pathways
PI3K/Akt/mTOR signaling|||Chromatin/Epigenetic|||Stem Cells|||Apoptosis|||DNA Damage/DNA Repair|||Proteases/Proteasome|||Cytoskeletal Signaling
Bioactivity
AKT-IN-28 is an allosteric inhibitor of Akt and a derivative of Shikonin. It effectively binds to Akt's allosteric site through hydrophobic and hydrogen bond interactions, with a Kd value of 2.07??M. AKT-IN-28 significantly inhibits Akt activity, inducing apoptosis in KRAS-mutant colorectal cancer cells, arresting the cell cycle at the G2/M phase, and suppressing cell proliferation, migration, and metabolism.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6356898-01 0.1 mL
TNFRSF10A, CT (TNFRSF10A, APO2, DR4, TRAILR1, Tumor necrosis factor receptor superfamily member 10A, Death receptor 4, TNF-related apoptosis-inducing ligand receptor 1, CD261) (MaxLight 750)
Ask
View Details MBS6356898-02 5x 0.1 mL
TNFRSF10A, CT (TNFRSF10A, APO2, DR4, TRAILR1, Tumor necrosis factor receptor superfamily member 10A, Death receptor 4, TNF-related apoptosis-inducing ligand receptor 1, CD261) (MaxLight 750)
Ask
View Details